Form'Veno
Food supplement declared in France, declaration No 2022-2-1278, decision dated 24 February 2022
Form'Veno is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- NFB Healthcare
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 2 gélules par jour
- Directions for use
- Prendre 2 gélules par jour avec un verre d'eau.
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes, Sous anticoagulants
- Objectives stated by the manufacturer (these are not authorised claims)
- Circulation sanguine et lymphatique
Declaration 314968, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Aesculus hippocastanum L. | Graine | Extrait sec aqueux | 340 mg |
| Vitis vinifera L. | Feuille | Extrait sec aqueux | 220 mg |
| Hamamelis virginiana L. | Feuille | Extrait sec aqueux | 200 mg |
| Ruscus aculeatus L. | Rhizome | Extrait sec alcoolique | 90 mg |
Additives
E464, E414
Other ingredients
huile de tournesol
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
Déconseillé aux femmes enceintes et allaitantes, et aux personnes sous traitement anticoagulant.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.